These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8109921

  • 41. Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii.
    Musso D, Drancourt M, Osscini S, Raoult D.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):870-3. PubMed ID: 8849242
    [Abstract] [Full Text] [Related]

  • 42. Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa.
    Yoshida T, Muratani T, Iyobe S, Mitsuhashi S.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1466-9. PubMed ID: 7979273
    [Abstract] [Full Text] [Related]

  • 43. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis.
    Kanematsu E, Deguchi T, Yasuda M, Kawamura T, Nishino Y, Kawada Y.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):433-5. PubMed ID: 9527801
    [Abstract] [Full Text] [Related]

  • 44. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
    Kaneko A, Sasaki J, Shimadzu M, Kanayama A, Saika T, Kobayashi I.
    J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
    [Abstract] [Full Text] [Related]

  • 45. Quinolone mode of action--new aspects.
    Hooper DC.
    Drugs; 1993 Jun; 45 Suppl 3():8-14. PubMed ID: 7689456
    [Abstract] [Full Text] [Related]

  • 46. Mutations in the gyrA and grlA genes of quinolone-resistant clinical isolates of methicillin-resistant Staphylococcus aureus.
    Takahata M, Yonezawa M, Kurose S, Futakuchi N, Matsubara N, Watanabe Y, Narita H.
    J Antimicrob Chemother; 1996 Sep; 38(3):543-6. PubMed ID: 8889728
    [Abstract] [Full Text] [Related]

  • 47. Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC.
    Gibreel A, Sjögren E, Kaijser B, Wretlind B, Sköld O.
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3276-8. PubMed ID: 9835526
    [Abstract] [Full Text] [Related]

  • 48. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.
    Deguchi T, Fukuoka A, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y, Ishihara S, Ban Y, Kawada Y.
    Antimicrob Agents Chemother; 1997 Mar; 41(3):699-701. PubMed ID: 9056017
    [Abstract] [Full Text] [Related]

  • 49. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.
    Valdezate S, Vindel A, Echeita A, Baquero F, Cantó R.
    Antimicrob Agents Chemother; 2002 Mar; 46(3):665-71. PubMed ID: 11850246
    [Abstract] [Full Text] [Related]

  • 50. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD, Zaniewski RP, Haskell SL, Kaczmarek FS, Maurice AE.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [Abstract] [Full Text] [Related]

  • 51. Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae.
    Tanaka M, Otsuki M, Nishino T, Kobayashi I, Matsumoto T, Kumazawa J.
    Genitourin Med; 1996 Aug; 72(4):295-7. PubMed ID: 8976839
    [Abstract] [Full Text] [Related]

  • 52. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY, Siu LK, Chen YH, Lu PL, Ho M, Peng CF.
    Microb Drug Resist; 2001 Aug; 7(1):47-53. PubMed ID: 11310803
    [Abstract] [Full Text] [Related]

  • 53. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.
    Wang Y, Huang WM, Taylor DE.
    Antimicrob Agents Chemother; 1993 Mar; 37(3):457-63. PubMed ID: 8384814
    [Abstract] [Full Text] [Related]

  • 54. High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain.
    Alarcón T, Pita J, López-Brea M, Piddock LJ.
    J Antimicrob Chemother; 1993 Oct; 32(4):605-9. PubMed ID: 8288502
    [Abstract] [Full Text] [Related]

  • 55. Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis.
    Zirnstein G, Li Y, Swaminathan B, Angulo F.
    J Clin Microbiol; 1999 Oct; 37(10):3276-80. PubMed ID: 10488192
    [Abstract] [Full Text] [Related]

  • 56. Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis.
    Peterson ML, Rotschafer JC, Piddock LJ.
    J Antimicrob Chemother; 2003 Sep; 52(3):481-4. PubMed ID: 12917248
    [Abstract] [Full Text] [Related]

  • 57. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.
    Ruiz J, Castro D, Goñi P, Santamaria JA, Borrego JJ, Vila J.
    J Med Microbiol; 1997 Jul; 46(7):623-8. PubMed ID: 9236748
    [Abstract] [Full Text] [Related]

  • 58. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.
    Weigel LM, Steward CD, Tenover FC.
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2661-7. PubMed ID: 9756773
    [Abstract] [Full Text] [Related]

  • 59. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
    Yoshida H, Nakamura M, Bogaki M, Nakamura S.
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1273-5. PubMed ID: 2168149
    [Abstract] [Full Text] [Related]

  • 60. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Ezaki T, Saito I, Kawada Y.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1020-3. PubMed ID: 8849219
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.